Alexion Pharmaceuticals, Inc.
Summary
Alexion Pharmaceuticals, Inc. is registered in the United States. Its legal form is Corporation. Alexion Pharmaceuticals, Inc. is the ultimate parent of a group of 4 subsidiaries in 4 countries, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. The LEI was first issued on 6 Jun 2012 and the record was last updated on 4 Aug 2023. It has lapsed: renewal was due by 13 Jan 2019. GLEIF's ISIN mapping lists 3 ISINs for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 13 Jan 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 2286486 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O Corporation Service Company, 251 Little Falls Drive, 19808 Wilmington, United States |
| Headquarters address | 100 College Street, 06510 New Haven, United States |
| Category | company or other legal entity |
| Status | active |
| LEI | M1YXUUZR0EIMU8T0EM75 |
| LEI status | lapsed |
| LEI first issued | 6 Jun 2012 |
| LEI record last updated | 4 Aug 2023 |
| Next LEI renewal | 13 Jan 2019 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
- Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
ISINs mapped to this LEI (3)
US0153511094 · US0153512084 · US0153513074
3 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
Other names
- UDEC Pharmaceuticals, Inc. · previous name